Literature DB >> 32539167

Aminoglycoside Conjugation for RNA Targeting: Antimicrobials and Beyond.

Klara Aradi1, Audrey Di Giorgio1, Maria Duca1.   

Abstract

Natural aminoglycosides are therapeutically useful antibiotics and very efficient RNA ligands. They are oligosaccharides that contain several ammonium groups able to interfere with the translation process in prokaryotes upon binding to bacterial ribosomal RNA (rRNA), and thus, impairing protein synthesis. Even if aminoglycosides are commonly used in therapy, these RNA binders lack selectivity and are able to bind to a wide number of RNA sequences/structures. This is one of the reasons for their toxicity and limited applications in therapy. At the same time, the ability of aminoglycosides to bind to various RNAs renders them a great source of inspiration for the synthesis of new binders with improved affinity and specificity toward several therapeutically relevant RNA targets. Thus, a number of studies have been performed on these complex and highly functionalized compounds, leading to the development of various synthetic methodologies toward the synthesis of conjugated aminoglycosides. The aim of this review is to highlight recent progress in the field of aminoglycoside conjugation, paying particular attention to modifications performed toward the improvement of affinity and especially to the selectivity of the resulting compounds. This will help readers to understand how to introduce a desired chemical modification for future developments of RNA ligands as antibiotics, antiviral, and anticancer compounds.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  RNA; aminoglycosides; antibiotics; conjugation; structure-activity relationships

Year:  2020        PMID: 32539167     DOI: 10.1002/chem.202002258

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  4 in total

1.  Potential for the Development of a New Generation of Aminoglycoside Antibiotics.

Authors:  A N Tevyashova; K S Shapovalova
Journal:  Pharm Chem J       Date:  2022-01-13       Impact factor: 0.837

Review 2.  Amphiphilic Aminoglycosides as Medicinal Agents.

Authors:  Clément Dezanet; Julie Kempf; Marie-Paule Mingeot-Leclercq; Jean-Luc Décout
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

3.  Geneticin shows selective antiviral activity against SARS-CoV-2 by targeting programmed -1 ribosomal frameshifting.

Authors:  Carmine Varricchio; Gregory Mathez; Laurent Kaiser; Caroline Tapparel; Andrea Brancale; Valeria Cagno
Journal:  bioRxiv       Date:  2022-03-08

4.  Design and Implementation of Synthetic RNA Binders for the Inhibition of miR-21 Biogenesis.

Authors:  Chloé Maucort; Duc Duy Vo; Samy Aouad; Coralie Charrat; Stéphane Azoulay; Audrey Di Giorgio; Maria Duca
Journal:  ACS Med Chem Lett       Date:  2021-05-14       Impact factor: 4.632

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.